| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 333.159.489 $ | +167.618.976 $ | +182,9 % | 15 | 214.286.461 $ | +214.286.461 $ | 10 | |||||
| Cidara Therapeutics, Inc. | → 0 | 51.305.899 $ | +51.305.899 $ | 1 | |||||||
| RELMADA THERAPEUTICS, INC. | RLMD | → 0 | Neutral | 42.998.208 $ | +23.261.954 $ | +117,9 % | 1 | 19.736.254 $ | +19.736.254 $ | 1 | |
| Kiniksa Pharmaceuticals International, plc | KNSA | → 0 | Stark | 36.645.183 $ | +18.702.175 $ | +104,2 % | 1 | 17.943.008 $ | +17.943.008 $ | 1 | |
| LB PHARMACEUTICALS INC | LBRX | → 0 | Neutral | 33.644.866 $ | +11.260.366 $ | +50,3 % | 1 | 22.384.500 $ | +22.384.500 $ | 1 | |
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 31.325.154 $ | +19.067.775 $ | +155,6 % | 1 | 12.257.379 $ | +12.257.379 $ | 1 | |
| Relay Therapeutics, Inc. | RLAY | → 0 | Schwach | 29.692.044 $ | +4.446.346 $ | +17,6 % | 1 | 25.245.698 $ | +25.245.698 $ | 1 | |
| Alto Neuroscience, Inc. | ANRO | → 0 | Neutral | 29.116.321 $ | +25.149.698 $ | +634,0 % | 1 | ||||
| Centessa Pharmaceuticals plc | CNTA | → 0 | 19.456.802 $ | +17.506.097 $ | +897,4 % | 1 | |||||
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 14.278.150 $ | -4.194.460 $ | -22,7 % | 1 | 18.472.610 $ | +18.472.610 $ | 1 | |
| Savara Inc | SVRA | → 0 | Stark | 18.472.136 $ | +3.933.245 $ | +27,1 % | 1 | 14.538.891 $ | +14.538.891 $ | 1 | |
| KalVista Pharmaceuticals, Inc. | KALV | → 0 | 18.070.319 $ | +11.804.636 $ | +188,4 % | 1 | |||||
| EyePoint, Inc. | EYPT | → 0 | Sehr schwach | 17.932.791 $ | +17.932.791 $ | 1 | |||||
| Erasca, Inc. | ERAS | → 0 | Neutral | 14.469.431 $ | +14.469.431 $ | 1 | |||||
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 12.897.035 $ | +6.027.341 $ | +87,7 % | 1 | ||||
| Surrozen, Inc./DE | SRZN | → 0 | Neutral | 12.585.325 $ | +2.821.221 $ | +28,9 % | 1 | ||||
| ENANTA PHARMACEUTICALS INC | ENTA | → 0 | Neutral | 11.778.713 $ | +5.633.349 $ | +91,7 % | 1 | ||||
| Alkermes plc. | ALKS | → 0 | Stark | 11.244.197 $ | +11.244.197 $ | 1 | |||||
| Perspective Therapeutics, Inc. | CATX | → 0 | Neutral | 10.955.036 $ | +10.955.036 $ | 1 | |||||
| 333.159.489 $ | +167.618.976 $ | +182,9 % | 15 | 214.286.461 $ | +214.286.461 $ | 10 | |||||